lobbying_activities: 623354

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
623354	29063c95-802c-4309-8fc6-96b3769330ed	Q2	CAPITOL HILL CONSULTING GROUP	72053	ELI LILLY AND COMPANY	2008	second_quarter	PHA	General Pharmaceutical issues pertaining to Eli Lilly and Company, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug importation	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2008-07-09T10:51:32-04:00